Chronic Kidney Disease

Investigators identified tumor necrosis factor receptor 1 as the most frequently studied plasma biomarker in the setting of chronic kidney disease progression.

Among patients with advanced chronic kidney disease, increasing dietary potassium consumption to recommended levels can increase blood potassium concentration on a short-term basis, according to results of this study.

Due to a significant association between the urine to phosphate-to-creatinine ratio and mortality among individuals without chronic kidney disease, researchers suggest this may be a predictor for future adverse events in this population.

Among patients with chronic kidney disease and albuminuria treated with dapagliflozin, researchers did not identify a correlation between acute reduction in eGFR and higher rates of CKD progression.

A new report from the Milken Institute recommends that health officials prioritize identification of the root causes of health inequity that contribute to kidney disease in efforts to slow down its occurrence.

Researchers identified the distance between a household and a supermarket as a risk factor for chronic kidney disease, hypertension and diabetes development.

A subanalysis of the FIDELITY trial showed finerenone reduced risk for all-cause and CV mortality, including sudden cardiac death, compared with placebo in adults with type 2 diabetes and chronic kidney disease.

Routine coronary angiography with revascularization when appropriate did not reduce 5-year mortality risk in patients with advanced chronic kidney disease and ischemia compared with an initial strategy of medical therapy.

The three-way merger of InterWell Health, Cricket Health and Fresenius Health Partners has been completed, according to a press release.

Black adults showed a higher prevalence for gout than white adults during a 10-year period, even after adjusting for diet, social determinants of health and chronic kidney disease, according to data published in JAMA Network.